Inventor · disambiguated record
Emanuela Gancia
Also filed as: GANCIA EMANUELA
20 granted patents·12 pending applications·53 citations·filing 2005–2025
90Inventor score
Files withGENENTECH INC20KALVISTA PHARMACEUTICALS LTD3CHEN HUIFEN2X BIOTIX THERAPEUTICS INC2CHDI FOUNDATION INC1
Top patents by PatentIndex Score
32 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0291US8492427B2Isoindolones derivatives as MEK kinase inhibitors and methods of useGANCIA EMANUELA·Filed 2009·Granted Jul 23, 2013·36 cites·13 claims
- 0390US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0481US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0580US8501765B2Diazacarbazoles and methods of useCHEN HUIFEN·Filed 2009·Granted Aug 6, 2013·4 cites·37 claims
- 0675US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0773US12421242B2Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditionsKARUNA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·50 claims
- 0868US9751873B2Aryl sultam derivatives as RORc modulatorsGENENTECH INC·Filed 2016·Granted Sep 5, 2017·1 cites·8 claims
- 0967US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 1066US10131644B2Aryl sultam derivatives as RORc modulatorsGENENTECH INC·Filed 2016·Granted Nov 20, 2018·1 cites·15 claims
- 1164US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 1262US2011124654A1Diazacarbazoles and methods of useCHEN HUIFEN·Filed 2009·Application pending·0 cites
- 1362US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1460US9090628B2Benzoxazepin compounds selective for PI3K P110 delta and methods of useHEFFRON TIMOTHY·Filed 2012·Granted Jul 28, 2015·1 cites·6 claims
- 1560US2024199624A1Compounds, compositions, and methodsCHDI FOUNDATION INC·Filed 2023·Application pending·0 cites
- 1659US12227475B2Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditionsX BIOTIX THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·21 claims
- 1758US9216980B2Methods of use of diazacarbazoles for treating cancerGENENTECH INC·Filed 2014·Granted Dec 22, 2015·0 cites·37 claims
- 1855US2013261104A1Methods of use of diazacarbazoles for treating cancerGENENTECH INC·Filed 2013·Application pending·0 cites
- 1954US12208088B2Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofGENENTECH INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 2054US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 2153US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 2253US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 2353US2015368244A1Diazacarbazoles and methods of useGENENTECH INC·Filed 2013·Application pending·0 cites
- 2450US2025171400A1Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditionsX BIOTIX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2546US2022363668A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 2643US11008312B2Pyridazine derivatives as RORc modulatorsGENENTECH INC·Filed 2019·Granted May 18, 2021·0 cites·9 claims
- 2743US7592456B2Arylsulfonylnaphthalene derivatives as 5HT2A antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Sep 22, 2009·0 cites·10 claims
- 2843US2022298138A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2943US2022298141A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 3042US10259808B2Aryl sultam derivatives as RORc modulatorsGENENTECH INC·Filed 2017·Granted Apr 16, 2019·0 cites·11 claims
- 3141US10280144B2Pyridazine derivatives as RORc modulatorsGENENTECH INC·Filed 2017·Granted May 7, 2019·0 cites·14 claims
- 3239US2015197529A1ARYL SULTAM DERIVATIVES AS RORc MODULATORSGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emanuela Gancia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →